Evidence map›Paper›PMID 39639496›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Targeted SPP1 Inhibition of Tumor-Associated Myeloid Cells Effectively Decreases Tumor Sizes.

Benan Kartal, Christopher S Garris, Hyung Shik Kim, Rainer H Kohler, Jasmine Carrothers, Elias A Halabi, Yoshiko Iwamoto, Anne-Gaëlle Goubet, Yuxuan Xie, Pratyaksha Wirapati and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Multiregional profiling revealsScience advances · 2026
    Article
  4. Article
  5. Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Transcriptional Repression of CCL2 by KInternational journal of molecular sciences · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Targeted SPP1 Inhibition of Tumor-Associated Myeloid Cells Effectively Decreases Tumor Sizes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. SPP1Research (Washington, D.C.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Benan KartalCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Christopher S GarrisCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Hyung Shik KimCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Rainer H KohlerCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Jasmine CarrothersCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Elias A HalabiCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Yoshiko IwamotoCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
Anne-Gaëlle GoubetDepartment of Pathology and Immunology, University of Geneva, Geneva, 1211, Switzerland.
Yuxuan XieDepartment of Pathology and Immunology, University of Geneva, Geneva, 1211, Switzerland.
Pratyaksha WirapatiDepartment of Pathology and Immunology, University of Geneva, Geneva, 1211, Switzerland.
Mikaël J PittetDepartment of Pathology and Immunology, University of Geneva, Geneva, 1211, Switzerland.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.

Funding

FAST-FNA immune cell profiling in HNSCCR01CA257623 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FAQUIN, WILLIAM CLAY, WEISSLEDER, MD, PHD, RALPH · 2021 to 2025
$3.3M
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapyR01CA281735 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI RALPH WEISSLEDER, MD, PhD · 2023 to 2026
$2.3M
Bioorthogonal probe development for highly parallel in vivo imagingR33CA277820 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2023 to 2025
$1.2M
NCI NIH HHS R01 CA257623NCI NIH HHS R01CA257623NCI NIH HHS R01 CA281735NCI NIH HHS R01CA281735NCI NIH HHS R33 CA277820NCI NIH HHS R33CA277820Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung P2EZP2_191831(EAH)Studienstiftung des Deutschen Volkes (BK)
6 · The paper itself

Abstract

Secreted phosphosprotein 1 (SPP1)

Indexed as

Myeloid CellsNeoplasmsOsteopontinTumor-Associated MacrophagesAnimalsCell Line, TumorHumansMacrophagesMiceOsteopontincancermacrophagenanoparticlesSPP1

Identifiers

PMID39639496
PMCPMC11775521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.